These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20564207)

  • 21. Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression.
    Zeng SY; Chen X; Chen SR; Li Q; Wang YH; Zou J; Cao WW; Luo JN; Gao H; Liu PQ
    Can J Cardiol; 2013 Oct; 29(10):1310-9. PubMed ID: 23850346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pik3ip1 modulates cardiac hypertrophy by inhibiting PI3K pathway.
    Song HK; Kim J; Lee JS; Nho KJ; Jeong HC; Kim J; Ahn Y; Park WJ; Kim DH
    PLoS One; 2015; 10(3):e0122251. PubMed ID: 25826393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silibinin protects H9c2 cardiac cells from oxidative stress and inhibits phenylephrine-induced hypertrophy: potential mechanisms.
    Anestopoulos I; Kavo A; Tentes I; Kortsaris A; Panayiotidis M; Lazou A; Pappa A
    J Nutr Biochem; 2013 Mar; 24(3):586-94. PubMed ID: 22818713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
    Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
    Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.
    Li HL; Huang Y; Zhang CN; Liu G; Wei YS; Wang AB; Liu YQ; Hui RT; Wei C; Williams GM; Liu DP; Liang CC
    Free Radic Biol Med; 2006 May; 40(10):1756-75. PubMed ID: 16767845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
    Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
    J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isorhamnetin protects against cardiac hypertrophy through blocking PI3K-AKT pathway.
    Gao L; Yao R; Liu Y; Wang Z; Huang Z; Du B; Zhang D; Wu L; Xiao L; Zhang Y
    Mol Cell Biochem; 2017 May; 429(1-2):167-177. PubMed ID: 28176246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
    Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
    Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Noncoding RNA FTX Reduces Hypertrophy of Neonatal Mouse Cardiac Myocytes and Regulates the PTEN/PI3K/Akt Signaling Pathway by Sponging MicroRNA-22.
    Yang X; Tao L; Zhu J; Zhang S
    Med Sci Monit; 2019 Dec; 25():9609-9617. PubMed ID: 31840653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear Localization Leucine-Rich-Repeat Protein 1 Deficiency Protects Against Cardiac Hypertrophy by Pressure Overload.
    Zong J; Li FF; Liang K; Dai R; Zhang H; Yan L; Liu JL; Xu LH; Qian WH
    Cell Physiol Biochem; 2018; 48(1):75-86. PubMed ID: 30001530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway.
    Cai J; Yi FF; Bian ZY; Shen DF; Yang L; Yan L; Tang QZ; Yang XC; Li H
    J Cell Mol Med; 2009 May; 13(5):909-25. PubMed ID: 19413885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway.
    Wu L; Gao L; Zhang D; Yao R; Huang Z; Du B; Wang Z; Xiao L; Li P; Li Y; Liang C; Zhang Y
    Free Radic Biol Med; 2018 Jun; 121():215-230. PubMed ID: 29733904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts.
    Cao T; Gao Z; Gu L; Chen M; Yang B; Cao K; Huang H; Li M
    PLoS One; 2014; 9(8):e103793. PubMed ID: 25099270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
    Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
    Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload.
    Zhou H; Bian ZY; Zong J; Deng W; Yan L; Shen DF; Guo H; Dai J; Yuan Y; Zhang R; Lin YF; Hu X; Li H; Tang QZ
    Hypertension; 2012 Sep; 60(3):802-9. PubMed ID: 22851736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling.
    Huang H; Tang QZ; Wang AB; Chen M; Yan L; Liu C; Jiang H; Yang Q; Bian ZY; Bai X; Zhu LH; Wang L; Li H
    Hypertension; 2010 Aug; 56(2):232-9. PubMed ID: 20585109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy.
    Pei H; Wang W; Zhao D; Su H; Su G; Zhao Z
    Int J Biol Sci; 2019; 15(1):81-92. PubMed ID: 30662349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
    Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
    Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
    Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.